Guest editorial : introduction of Progress in Hematology in this issue

スポンサーリンク

概要

• 論文の詳細を見る
• 2012-01-01

著者

• Miyazaki Yasushi

  Atomic Bomb Disease And Hibakusha Medicine Unit Department Of Hematology Atomic Bomb Disease Institute Nagasaki University Graduate School Of Biomedical Sciences

関連論文

• Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
• Guest editorial : introduction of Progress in Hematology in this issue

スポンサーリンク